Pearce IP | South Korea | 11 Mar 2024
On 11 March 2024, Korea Biomedical Review reported that Merck Sharp & Dohme (MSD)’s anti-PD-1 therapy Keytruda (pembrolizumab) was approved in Korea…
Ropes & Gray LLP | Asia-Pacific, China, India, etc. | 8 Mar 2024
The recent BioCentury East-West Summit in Singapore shed light on the increasing prominence of Asia in the global life sciences industry, with Asia…
Pearce IP | Australia, Canada, European Union, etc. | 4 Mar 2024
The Australian Financial Review reported that on 1 March 2024 TGA investigators raided Como Compounding Pharmacy in Melbourne and seized ‘off-brand’…
Bristows | European Union, South Korea, United Kingdom | 1 Mar 2024
The Irides Weekly Update is our round-up of patent litigation news highlights from around the world. Taking its name from the plural of “iris” - a…
Pearce IP | South Korea | 28 Feb 2024
On 28 February 2024, Celltrion announced that it filed an application with MFDS for CT-P47, biosimilar to Genentech’s Actemra® (tocilizumab). The…
Yulchon LLC | South Korea | 27 Feb 2024
율촌 입법 위클리는 한 주간의 입법 및 정책 동향 중 특히 기업의 규제 대응 담당자 및 의사결정권자들이…
Pearce IP | South Korea | 26 Feb 2024
On 26 February 2024, Daily Pharm Korea reported that Samsung Bioepis received approval from the Korean Ministry of Food and Drug Safety for Afilivu®…
Bae, Kim & Lee LLC | South Korea | 20 Feb 2024
식품의약품안전처는 2024. 2. 19. “식의약 안심이 일상이 되는 세상”을 비전으로 하는 「2024년 식약처 주요 업무 추진계획」을 발표하였습니다. 법무법인(유한) 태평양은 정부가 발표한 ‘안전에 신뢰를 더하는 과학’, ‘기대를 현실로 만드는 현장’, ‘안전의…